Publications‎ > ‎

From year (2006- 2010)

  • Azim HA, Bahr SA, Koura MA, Gad H, Farouk M, Morsy A, Iskander I, Hammad A, Fat'hy M, Attia H, Sadek K. Case Study in Refractory Non-Hodgkin's Lymphoma: Successful Treatment with Plerixafor. Case Rep Oncol. 2011 Sep;4(3):467-9.

  • Azim H, Azim HA Jr, Escudier B. Targeting mTOR in cancer: renal cell is just a beginning.Target Oncol. 2010 Dec;5(4):269-80

  • Bazarbachi A, Azim HA, Alizadeh H, Aljurf M, Barista I, Chaudhri NA, Fahed Z, Fahmy OA, Ghavamzadeh A, Khalaf MH, Khatib S, Kutoubi A, Paydas S, Elayoubi HR, Zaatari G, Zawam HM, Zelenetz AD; MENA Lymphoma Regional Guidelines Committee. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S29-35.

  • H.A. Azim, L. Santoro, R.G. Bociek, S. Gandini, R.A. Malek1 & H.A. Azim Jr. High dose intensity doxorubicin in aggressive non-Hodgkin’s lymphoma: a literature-based meta-analysis. Annals of Oncology 21: 1064–1071, 2010

  • Azim HA Jr, Azim H, Peccatori FA.Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev Clin Immunol. 2010 Nov;6(6):821-6.

  • Azim HA, Jazieh AR, Jahanzeb M. The NCCN MENA (Abu Dhabi declaration): why the hustle? J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S2-4

  • Azim H, Azim HA Jr, Escudier B.Trastuzumab versus lapatinib: the cardiac side of the story. Cancer Treat Rev. 2009 Nov;35(7):633-8

  • Hatem A. Azim Jr , Inas Elattar , Fausto R. Loberiza Jr , Hamdy Azim,Tony Moke, Apar Kishor Ganti: Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: A systematic overview. Lung  Cancer 64 (2009) 194–198

  • H Azim, Neemat M Kassem, Elia A Isaak, Rania H Khalifa, Inas El Sissy, Azza Mohamed CK- 19 AS A PREDICTOR FOR MICROMETASTASIS IN BREAST CANCER: A PILOT STUDY DONE ON NON-METASTATIC FEMALE BREAST CANCER PATIENTS.  Egypt. J. Lab. Med. Vol.(21) 2009, 1-10.

  • Hamdy Azim and  Hatem A. Azim Jr: Targeting Her-2/neu in Breast Cancer :As Easy as This! .Oncology 2008;74:150–157

  • Azim HA, Azim HA Jr. optimizing the use of her-2/neu targeting agents in breast cancer : a developing nation perspective. J Egypt Natl Canc Inst. 2007 Dec;19(4):225

  • Azim HA, Elsedewy E, Azim HA Jr.Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature Onkologie. 2007 Jul;30(7):381-4      

  • Azim HA, Azim HA Jr, Seoudi H. Gemcitabine/Oxaliplatin in irressectable cancer pancreas: A case report BMJ (Middle East edition); Volume 12, Jan 2005

  • Azim HA, Salam MA, Azim HA. Temozolamide in the treatment of brain metastasis of mammary origin: A case study. BMJ (Middle East edition); Volume 12, Jan 20,2005

  • Ghoneimy E, Moustafa M, Abdallah M, AbdelSalam M, Atef H, Abdel-Hady E, Abdel-Azim H. The use of temozolomide in the management of high grade gliomas at relapse. Medical Journal of Cairo University    2003;71(1):147-157

  • Giles FJ, Shan J, Advani SH, Akan H, Aydogdu I, Aziz Z, Azim HA, Bapsy PP, Buyukkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, et al. International Oncology Study Group NHL1 Study. A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1 Study .Leuk Lymphoma. 2000 Dec;40(1-2):95-103

  • Azim H, Sheba H. Evaluation of the effect of different culture conditions on the lineage selected proliferation of megakaryocyte stem cell. Kasr El Aini Medical Journal 2000;6(3):173-200.

  • Azim HA.Treatment of metastatic breast cancer by navelbine, mitoxantrone and continuous infusion 5-fluorouracil (FMN regimen): results of a pilot study. J Infus Chemother. 1996 Spring;6(2):102-6

  • El-Ghamrawy KA, Zawam HZ, Abdel-Azim H, Haggag M. Risk factors in intermediate and high-grade non-Hodgkins lymphomas of adults: a need for a new staging system. Anticancer Drugs 1996;2(4):383-388

  • Azim HA, Diab M, Sedky L, Mansour M, Mousa M, Hamada E. Treatment of cisplatin-induced vomiting by   tropisetron: results of a pilot study. Medical Journal of Cairo University 1996;64(1):63-70

  • Hamdy Abdel Azim , Sedky L, Mousa M, El-Ghamrawy K. The superiority of high dose chemotherapeutic regimens in the treatment of pediatric Non-Hodgkins lymphoma Medical Journal of Cairo University 1996;64(3):133-146

  • Ghamrawy KA, Azim HA, Sedky LM, Mansour M, Hussein MM, Mousa M, Saad M. Recombinant human GM-CSF with intensive chemotherapy in the treatment of high risk non-Hodgkin's lymphoma: results of a randomized trial. Medical Journal of Cairo University Medical Journal of Cairo University 1996;64

  • Ghamrawy KA, Kader YA, Mansour M, Azim HA, Sedky L, Mousa MM, Saad M, Seleem H. Treatment of chronic myelogenous leukemia with interferons (IFN). Medical Journal of Cairo University 1995;63(3):45-57.

  • Ghamrawy KA, Azim HA, Sedky LM, Mansour M, Hussein MM, Mousa M, Saad M. High dose epirubicin versus mitoxantrone in a seven-drug combination regimen for intermediate and high grade NHL: results of a randomized    pilot study. Medical journal of Cairo University Medical Journal of Cairo University 1996;64(3)

  • Azim HA, Abul Nasr M, Badran A. Breast conserving treatment of operable mammary cancer: rationale and outcome of a suggested protocol. Egyptian Journal of Surgery 1995;14(3):93-106

  • Azim HA, Saad M, Sedky L, Moussa M, El-Ghamrawy K. Efficacy of oral fluconazole in the treatment of cancer patients with oropharyngeal candidiasis. Journal of the Egyptian National Cancer Institute 1995;7(2):191-19

  • Zawam HM, Haggag M, Azim HA, Mansour M. Epirubicin, bleomycin, vinblastine and prednisone (EBVP) in the management of Hodgkin's disease. Medical Journal of Cairo University 1993;61(3):653-659

  • Azim HA. El-Haddad SI, Salem DS, Hashem MB, Hassan A. Malignant mesothelioma: Epidemiology-diagnosis and treatment results of 46 cases. Medical Journal of Cairo University 1992;60(2):533-546

  • Azim HA, Badran AI. Conservative surgery and radical radiotherapy in the management of operable breast cancer. Egyptian Journal of Surgery 1992;11(3):55-62

  • Azim HA. Locally advanced breast cancer: a problem for a combined approach, Medical Journal of Cairo University, 1990;58(3):209-222

  • Azim HA, Badran AI, Abdel-Kader S. Treatment of metastatic colorectal carcinoma with 5-fluorouracil and folinic acid :a pilot study. Medical Journal of Cairo University 1990;58(2): 289-297

  • Ghamrawi K, Azim HA, El Zawam H. Value of protocol treatment of pediatric non-Hodgkins lymphoma. Medical Journal of Cairo University 1991;59(1):241-254

  • Azim HA, El-Haddad SI, Kader YA, Zawam HM. Ifosfamide and Adriamycin combination in the treatment of diffuse  malignant mesothelioma. Sci Med J Cai Med Synd 1991;3:77-92.

  • Salem S, Abdel-Azim H. The challenge of recurrent basal cell carcinoma. Medical Journal of Cairo University 1990;58(3):239-254

Comments